Literature DB >> 18805698

New potent cathepsin G phosphonate inhibitors.

Marcin Sieńczyk1, Adam Lesner, Magdalena Wysocka, Anna Legowska, Ewa Pietrusewicz, Krzysztof Rolka, Józef Oleksyszyn.   

Abstract

Cathepsin G is an enzyme with dual chymotrypsin and trypsin-like specificity. As a leukocyte proteinase it is involved in the early stages of the immune response. In this work the synthesis and inhibitory activity of diaryl phosphonic-type irreversible cathepsin G inhibitors are described. Modification of the lead structure Z-Phg(P)(OPh)2 (k(obs)/I=91 M(-1)s(-1)) in phenyl ester moieties followed by incorporation of the basic functional group into the aromatic side chain yielded highly potent cathepsin G inhibitor Z-(4-guanidine)Phg(P)(OC6H4-4-S-Me)2 with the apparent second-order inhibition value at 15,600 M(-1)s(-1). Further elongation of the obtained compound by tripeptide resulted in the inhibitor Ac-Phe-Val-Thr-(4-guanidine)Phg(P)(OC6H4-4-S-Me)2 with the highest k(obs)/I value ever reported in literature (256,000 M(-1)s(-1)).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18805698     DOI: 10.1016/j.bmc.2008.08.069

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice.

Authors:  Jing Wang; Galina K Sukhova; Jian Liu; Keith Ozaki; Adam Lesner; Peter Libby; Petri T Kovanen; Guo-Ping Shi
Journal:  J Vasc Surg       Date:  2014-07-16       Impact factor: 4.268

2.  Development of an SPR imaging biosensor for determination of cathepsin G in saliva and white blood cells.

Authors:  Ewa Gorodkiewicz; Elżbieta Regulska; Kazimierz Wojtulewski
Journal:  Mikrochim Acta       Date:  2011-03-02       Impact factor: 5.833

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.